Ann: Appendix 4E & Annual Report 2022, page-2

From the Chairman's Letter it states;

We are looking forward to another exciting and productive year for Alterity.

Another exciting year?? If the last year was exciting I'd hate to see a dull year.

The remuneration numbers for Stamler are ridiculous. They state that the remunerations are not based on performance but rather on Industry practices. I sometimes feel that this company is just a vehicle for a lucky few to line their pockets.

Their is also a fleeting mention of PBT2 and its ability to reverse antibiotic resistance.